Pepto-bismol Ultra | Bismuth Subsalicylate Tablet while Breastfeeding

What is Pepto-bismol Ultra | Bismuth Subsalicylate Tablet used for?

Is using Pepto-bismol Ultra | Bismuth Subsalicylate Tablet unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Bismuth subsalicylate while Breastfeeding

Bismuth salts are used alone or together with other components in preparations against gastritis and diarrhea.Bismuth salicylate contains about 60% bismuth and 40% salicylate. At latest update no published data on excretion into breast milk were found. Bismuth is not absorbed into the systemic circulation of the mother. There may be a risk of absorption of salicylate in the case of bismuth salicylate, although in small quantity (<1% of the maternal dose), but no cases of Reye's syndrome have been reported after taking bismuth salicylate or other non-acetylated salicylate compounds. Due to the otherwise minimum risk of Reye's syndrome and the indiscriminate use of bismuth subsalicylate for treatment of gastroenteritis cannot be justifiable since most of gastroenteritis do not require medication instead a simply adequate hydration, a safer alternative should be desirable while breastfeeding, like the other salts of bismuth (citrate, etc).

Bismuth subsalicylate while Breastfeeding

CAS Number: 14882-18-9

Because of the possibility of absorption of salicylate from the breastmilk by the infant, alternatives are preferred.[1]

What if I already have used Pepto-bismol Ultra | Bismuth Subsalicylate Tablet?

My health care provider has asked me to use Pepto-bismol Ultra | Bismuth Subsalicylate Tablet, what to do?

If I am using Pepto-bismol Ultra | Bismuth Subsalicylate Tablet, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Pepto-bismol Ultra | Bismuth Subsalicylate Tablet in breastfeeding?